Nanostructuring of Biomaterials—A Pathway to Bone Grafting Substitute

Background:The bone substitute NanoBone® consists of nanocrystalline hydroxyapatite embedded in a highly porous matrix of silica gel. It promotes the healing of bone defects and is degraded by osteoclasts during bone remodeling. The present study investigates the interactions of NanoBone® with bone tissue.Methods:Granules of NanoBone® were implanted in defects of critical size in the mandible of minipigs. Samples were taken after 5 and 10 weeks and demineralized. The composition of the implanted granules was analyzed by means of transmission and scanning electron microscopy and EDX. Enzymeand immunohistochemistry was used to investigate organic components of NanoBone® granules that arised after implantation in the host.Results:EDX demonstrated that 5 weeks after implantation the silica gel was degraded and replaced by an organic matrix. Ultrastructurally, the matrix appeared amorphous with only single collagen fibrillae.PAS-staining indicated the presence of carbohydrates. Immunohistochemically, the bone proteins osteopontin, osteocalcin and BMP-2 were found as constituents of the new matrix. Alkalic phosphatase activity was located in osteoblasts and newly formed bone on NanoBone® and focally in particles. Osteoclasts with ruffled borders, sealing zones, and acid phosphatase activity were situated in resorption lacunae at granule surfaces not covered by new bone.Conclusions:In vivo, the silica gel of NanoBone® is replaced by bone matrix glycoproteins with known functions in attraction, adhesion, and differentation of bone cells as osteoblasts and osteoclasts. We assume that the deposition of these molecules supports the early phase of NanoBone® degradation by osteoclasts and promotes the production of new bone tissue.

[1]  G. Gronowicz,et al.  Mineralization and the Expression of Matrix Proteins During In Vivo Bone Development , 1998, Calcified Tissue International.

[2]  T. Gerber,et al.  Macroscopical, histological, and morphometric studies of porous bone-replacement materials in minipigs 8 months after implantation. , 2006, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

[3]  M. McKee,et al.  Osteopontin at mineralized tissue interfaces in bone, teeth, and osseointegrated implants: Ultrastructural distribution and implications for mineralized tissue formation, turnover, and repair , 1996, Microscopy research and technique.

[4]  K. Henkel,et al.  Development and In Vivo Test of Sol-Gel Derived Bone Grafting Materials , 2003 .

[5]  G. Daculsi,et al.  The modulation of gene expression in osteoblasts by thrombin coated on biphasic calcium phosphate ceramic. , 2006, Biomaterials.

[6]  E. Bonucci,et al.  Alkaline phosphatase and tartrate-resistant acid phosphatase in osteoblasts of normal and pathologic bone. , 2001, Italian journal of anatomy and embryology = Archivio italiano di anatomia ed embriologia.

[7]  Elisabeth H Burger,et al.  Localisation of osteogenic and osteoclastic cells in porous beta-tricalcium phosphate particles used for human maxillary sinus floor elevation. , 2005, Biomaterials.

[8]  N. Amizuka,et al.  A histological evaluation of the involvement of Bio-Oss in osteoblastic differentiation and matrix synthesis. , 2004, Clinical oral implants research.

[9]  K. Schlegel,et al.  Expression of bone matrix proteins during de novo bone formation using a bovine collagen and platelet-rich plasma (prp)--an immunohistochemical analysis. , 2005, Biomaterials.

[10]  Nikitas Sykaras,et al.  Bone morphogenetic proteins (BMPs): how do they function and what can they offer the clinician? , 2003, Journal of oral science.

[11]  A. Sundan,et al.  Role of osteopontin in adhesion, migration, cell survival and bone remodeling. , 2004, Experimental oncology.

[12]  Benjamin M. Wu,et al.  Evolving concepts in bone tissue engineering. , 2005, Current topics in developmental biology.

[13]  M. Seibel,et al.  Molecular Markers of Bone Turnover , 2003 .

[14]  麻生 義則.  Osteopontin facilitates angiogenesis, accumulation of osteoclasts, and resorption in ectopic bone , 2001 .

[15]  M. Young.  Bone matrix proteins: their function, regulation, and relationship to osteoporosis , 2003, Osteoporosis International.

[16]  M. Noda,et al.  Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival. , 2001, The Journal of clinical investigation.

[17]  R. Derner,et al.  The bone morphogenic protein. , 2005, Clinics in podiatric medicine and surgery.

[18]  Hans-Georg Neumann,et al.  Silica/Calcium Phosphate Sol-Gel Derived Bone Grafting Material — From Animal Tests to First Clinical Experience , 2003 .